Blackstone Inc Revolution Medicines, Inc. Transaction History

Blackstone Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $126,241 - $182,977	6,081 Added 19.54%	37,197 $805,000
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $113,647 - $164,106	6,428 Added 26.04%	31,116 $741,000
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $130,950 - $195,000	7,500 Added 43.64%	24,688 $487,000
Q3 2021 Nov 16, 2021	SELL	$23.95 - $33.41 $9.57 Million - $13.3 Million	-399,441 Reduced 95.87%	17,188 $473,000
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $12.1 Million - $19.8 Million	416,629 New	416,629 $13.2 Million

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

Stay updated on Blackstone Inc with notifications on news.